>
>
Enteric Disease Testing Market - By Disease (Bacterial [C. difficile, E. coli, Salmonella, Campylobacter], Viral [Rotavirus], Parasitic [Amebiasis, Giardiasis]), Test Type (Immunoassay, Molecular, Conventional), End-use – Global Forecast, 2024 – 2032
Download Free PDF

Enteric Disease Testing Market
Get a free sample of this reportGet a free sample of this report Enteric Disease Testing Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 12
Tables & Figures: 397
Countries covered: 22
Pages: 228
Download Free PDF
Enteric Disease Testing Market Size
Enteric Disease Testing Market size was valued at around USD 3.7 billion in 2023 and is estimated to expand at 3.9% CAGR from 2024 to 2032. This high market growth can be primarily attributed to numerous factors including increasing prevalence of enteric diseases, growing concerns about food safety, continuous advancements in diagnostic technologies, and increasing healthcare expenditure and awareness across the globe.
Moreover, enteric diseases, which are infections of the gastrointestinal system caused by bacteria, viruses, or parasites, are prevalent across the world. Enteric diseases can be transmitted by contaminated food and water sources, inadequate sanitation, and close human-to-human contact. The growing prevalence of enteric infections demands accurate diagnostic tests to identify the causative agents, advise proper therapy, and prevent future transmission.
For instance, as per the stats reported by Centers for Disease Control and Prevention, in 2022 there were an estimated 9.4 million diseases, 56,000 hospital admissions, and 1,350 fatalities in the U.S. attributed to infections from major foodborne pathogens.
Moreover, public health surveillance systems are crucial in monitoring the prevalence, and trends of enteric disease on an individual, national, and globally scale. Surveillance data reveal insights into disease outbreaks, new pathogens, antibiotic resistance patterns, and healthcare use trends, allowing for prompt interventions and resource allocation methods. Enteric disease testing is a critical component of public health surveillance activities, enabling early diagnosis, containment, and control of infectious diseases, thereby contribute to the growth of the enteric disease testing market.
Enteric disease testing refers to the diagnostic evaluation conducted to identify infections and illnesses affecting the gastrointestinal tract, commonly known as the enteric system. The enteric system encompasses various organs and structures involved in the digestion and absorption of food, including the stomach, small intestine, large intestine (colon), rectum, and anus.
Enteric Disease Testing Market Trends
Growing trend towards the adoption of molecular diagnostics technique, surging demand for point-of-care testing, rise in foodborne illness surveillance, increasing need for integrated automation and robotics, and growing trends for personalized medicine and host response testing, among other factors are propelling the industry growth.
Enteric Disease Testing Market Analysis
The market by disease is categorized into bacterial enteric disease, viral enteric disease, and parasitic enteric diseases. The bacterial enteric disease segment is further divided into C. difficile, E. coli, salmonella, campylobacter, listeria, and shigellosis. The viral enteric disease segment is further bifurcated into rotavirus infection, and norovirus infection. The parasitic enteric disease segment is further divided into giardiasis, amebiasis, and cryptosporidiosis. The bacterial enteric disease segment accounted for majority share and was valued at over USD 2.1 billion revenue in 2023.
Based on test type, the enteric disease testing market is segmented into immunoassay, molecular, conventional, chromatography & spectrometry, and other test types. The immunoassay segment held leading revenue share in 2023 and is anticipated to reach USD 1.9 billion by 2032.
The enteric disease testing market by end-use is categorized into hospitals, diagnostic laboratories, research & academic institutes, and other end-users. The hospitals segment accounted for majority revenue share and was valued at around USD 1.4 billion revenue size in 2023.
North America enteric disease testing market accounted for USD 1.4 billion revenue in 2023 and is predicted to witness substantial market growth.
Enteric Disease Testing Market Share
The enteric disease testing industry is competitive in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products with improved efficiency and cost-effectiveness is among a key market strategy for manufacturers. Some of the leading industry players including Abbott Laboratories, Becton, Dickinson, and Company, Biomerica, Inc., BIOMÉRIEUX S.A, Bio-Rad Laboratories, Inc., among others have a substantial presence in the market.
Enteric Disease Testing Market Companies
Some of the eminent market participants operating in the enteric disease testing industry include:
Enteric Disease Testing Industry News:
Enteric disease testing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Disease ($ Mn)
Market, By Test Type ($ Mn)
Market, By End-use ($ Mn)
The above information is provided for the following regions and countries: